RadioBDC Logo
Fools Gold | Fitz & The Tantrums Listen Live
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Pfizer strikes deals to hold on to Lipitor market share

Cholesterol drug’s patent expires at end of November

Pfizer hopes to keep 40 percent of Lipitor users through May, six months after the drug’s patent protection expires. Pfizer hopes to keep 40 percent of Lipitor users through May, six months after the drug’s patent protection expires. (Matt Rourke/Associated Press/file)
By Drew Armstrong and Molly Peterson
Bloomberg News / November 15, 2011

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Pfizer Inc. is seeking to add Express Scripts Inc. to the list of U.S. pharmacy benefits managers that won’t dispense generic Lipitor after the world’s best-selling drug loses patent protection this month.

For more from BostonGlobe.com, sign up or log in below

To continue, please sign up or log in to BostonGlobe.com

Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com

Sign up

Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription.

BostonGlobe.com subscriber

Click to continue reading this article or to log in to BostonGlobe.com.